Sector
PharmaceuticalsOpen
₹2,550Prev. Close
₹2,564.45Turnover(Lac.)
₹47.83Day's High
₹2,610.45Day's Low
₹2,55052 Week's High
₹2,823.952 Week's Low
₹1,728.1Book Value
₹427.25Face Value
₹5Mkt Cap (₹ Cr.)
1,590.21P/E
41.2EPS
62.33Divi. Yield
0.0715 May 2023
12:00 AM
Dividend
Dividend Amount: 1.75
Record Date: 18 Aug, 2023
9 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
15 May 2023
12:00 AM
AGM
Announcement Date: 15 May, 2023
15 May 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 3.09 | 3.09 | 3.09 | 3.09 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 222.43 | 203.48 | 152.36 | 98.12 |
Net Worth | 225.52 | 206.57 | 155.45 | 101.21 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 318.66 | 258.18 | 152.18 | 113.65 |
yoy growth (%) | 23.42 | 69.65 | 33.89 | 13.97 |
Raw materials | -148.31 | -102.5 | -64.8 | -45.86 |
As % of sales | 46.54 | 39.7 | 42.58 | 40.35 |
Employee costs | -33.05 | -27.23 | -23.8 | -18.37 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 68.97 | 75.99 | 14.35 | 17.8 |
Depreciation | -7.67 | -7.39 | -7.26 | -4.56 |
Tax paid | -16.72 | -20.52 | -3.74 | -5.2 |
Working capital | 39.27 | 16.39 | 25.59 | -4.17 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 23.42 | 69.65 | 33.89 | 13.97 |
Op profit growth | -14.49 | 273.41 | -3.79 | -15.26 |
EBIT growth | -9.38 | 368.73 | -14.21 | -17.74 |
Net profit growth | -5.81 | 423.11 | -15.79 | -15.4 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 338.69 | 278.08 | 317.5 | 257.97 | 151.69 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 338.69 | 278.08 | 317.5 | 257.97 | 151.69 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 14.13 | 5.53 | 10.68 | 8.02 | 3.05 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Rahul J Nachane
Whole Time Director & CFO
Rajesh N Lawande
Chairman & Independent Directo
Milind V Shinde
Non-Exec & Non-Independent Dir
Ajita Nachane
Non-Exec. & Independent Dir.
Jayaram Sitaram
Company Sec. & Compli. Officer
Pallavi Pednekar
Independent Director
Sarala Menon
Additional Director
Dhananjay Mungale
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by NGL Fine Chem Ltd
Summary
NGL Fine-Chem Limited was incorporated on December 18, 1981 as a Private Limited Company in the State of Maharashtra. The Company became a Public Limited Company. The Company has got its registered office and factory at New Bombay. It was promoted by Mr. A.G.Lawande, Mr.R. J. Nachane joined Mr.A.G.Lawande for actively participating in the Management of the Company in 1989. The Company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It is presently engaged in chemical substances used in manufacture of pharmaceuticals and Allopathic medicines.The Company had at its commencement set up manufacturing facilities for the manufacture of Chloroquire Phosphate (antimalarial) which has a very good market at that time. But in absence of rain-fall in severe drought conditions during 1985-86 there was a very low incidence of malaria and the demand for the drug came down drastically. This forced a price war in the industry which led to the company being hit badly, ultimately leading to losses.During 1996-97, Company has faced illegal labor strike from October 1996. The Company is continuing operations by importing material and having it converted/processed from other units. The workers have been able to obtain an injunction from the labour court against the company which prevents the company from clearing any stocks from the factory. The Company carried out refurbishment of the plant and commenced its manufacturing activities in 2000-01. In
Read More
What is the NGL Fine Chem Ltd share price today?
The NGL Fine Chem Ltd shares price on N/A is Rs.₹2581.35 today.
What is the Market Cap of NGL Fine Chem Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of NGL Fine Chem Ltd is ₹1595.27 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of NGL Fine Chem Ltd?
The PE and PB ratios of NGL Fine Chem Ltd is 41.2 and 6.04 as of 22 Jul ‘24
What is the 52 Week High and Low of NGL Fine Chem Ltd?
The 52-week high/low is the highest and lowest price at which a NGL Fine Chem Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of NGL Fine Chem Ltd is ₹1711.3 and ₹2822.5 as of 22 Jul ‘24
What is the CAGR of NGL Fine Chem Ltd?
NGL Fine Chem Ltd's CAGR for 5 Years at 39.82%, 3 Years at -4.63%, 1 Year at 27.60%, 6 Month at 31.01%, 3 Month at 0.91% and 1 Month at 7.86%.
What is the shareholding pattern of NGL Fine Chem Ltd?
The shareholding pattern of NGL Fine Chem Ltd is as follows:
Promoters - 72.74 %
Institutions - 0.03 %
Public - 27.23 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
